Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

SARS-CoV-2 Mpro inhibitor, nirmatrelvir, found to reduce COVID-19 progression and death

In a new study, researchers evaluated the efficacy and safety of nirmatrelvir in mild to moderate COVID-19 patients who were at high risk of severe COVID-19 disease.

18 Feb 2022

VA researchers shine light on the dangerous mental health consequences of COVID-19

The most menacing fallout from COVID-19 often shows itself only after the initial "acute" infection passes. A team of VA researchers has been shining a light on various dangerous and enduring consequences that can arise following the initial COVID bout. These COVID complications include mental health disorders.

18 Feb 2022

‘I just want to stay in one spot’: From homeless to housed in rugged Del Norte

On a rainy winter morning, Jamie Hayden stopped in to visit with Diane Timothio. A case manager in Del Norte County on California's remote northern coast, Hayden comes by often, sometimes staying for hours, to work with Timothio.

18 Feb 2022

Study finds antigenic profile of Omicron RBD is distinct from the prior SARS-CoV-2 variants of concern

A new study aimed to clarify whether extensive RBD mutations could affect the magnitude and immunodominance hierarchy of the host antibody response.

18 Feb 2022

Covid-19 linked with an increased risk of mental health disorders, study finds

A study published by The BMJ today finds that covid-19 is associated with an increased risk of mental health disorders, including anxiety, depression, substance use, and sleep disorders, up to one year after initial infection.

17 Feb 2022

Ensitrelvir, a novel SARS-CoV-2 antiviral

S-217622 reduces the viral load and help alleviate the severity of SARS-CoV-2 in infected hamsters.

17 Feb 2022

New finding may aid in development of vaccines against future animal-to-human viral diseases

A future vaccine providing protection against a wide range of coronaviruses that jump from their original animal hosts to humans - including SARS-CoV-2, the cause of COVID-19 - may be possible, say Johns Hopkins Medicine researchers, based on findings from their recent study.

17 Feb 2022

COVID-19 survivors more likely to suffer from mental health problems

As the COVID-19 pandemic stretches into its third year, countless people have experienced varying degrees of uncertainty, isolation and mental health challenges.

17 Feb 2022

2022 adult immunization schedule released by ACIP

The Advisory Committee on Immunization Practices (ACIP) has released its 2022 Recommended Adult Immunization Schedule that includes changes to the zoster, pneumococcal, and hepatitis B vaccines.

17 Feb 2022

ChAdOx1 vaccine found to protect Syrian hamsters against SARS-CoV-2 variants

Researchers recently evaluated the efficacy of the Oxford ChAdOx1 (AZD 1222/ AZD2816) vaccine against the Omicron, Delta, and Beta variants of SARS-CoV-2 in Syrian hamsters.

17 Feb 2022

Vaccination likely to be more protective against SARS-CoV-2 viral variants than natural infection

Antibodies generated by COVID-19 vaccines are more suited to recognizing viral variants than antibodies that arise from natural infection, according to a study by researchers at Stanford Medicine.

17 Feb 2022

Frequency and function of SARS-CoV-2-specific T cells in individuals with pulmonary PASC

Researchers examined patients with pulmonary PASC of SARS-CoV-2 to determine the frequency and function of SARS-CoV-2-specific T cells in their blood.

17 Feb 2022

Study determines 115 long COVID symptoms and their associated risk factors

A new study determined which symptoms are linked with confirmed SARS-CoV-2 infection beyond 12 weeks post-infection in non-hospitalized individuals, and investigated the associated risk-factors of such symptoms.

17 Feb 2022

First cases of co-infection with Delta and Omicron identified during local co-circulation of both SARS-CoV-2 lineages

Researchers revealed the co-infection of the SARS-CoV-2 Delta and Omicron variants in two epidemiologically unrelated patients suffering from chronic kidney disease and requiring hemodialysis

17 Feb 2022

A novel consensus-based computational pipeline that reliably predicts hACE2-RBD binding affinity

Researchers developed a novel computational model to predict the binding affinity between the hACE2 receptor and the RBD of S protein of SARS-CoV-2.

17 Feb 2022

Smartphone-based COVID-19 detection system

In this interview, we speak to Professor Michael Mahan about his latest research which aimed to bring low-cost, state-of-the-art diagnostics to resource-limited settings.

17 Feb 2022

Study shows how some cancer cells immobilize T cells

Our immune systems have the potential to find and destroy cancer cells. But cancer cells can be clever and develop tricks to evade the immune system.

16 Feb 2022

Risk factors for COVID-19 in older adult patients with cancer

Researchers develop a geriatric risk score to predict the risk of severe clinical outcomes in older cancer patients with COVID-19.

16 Feb 2022

UC joins nationwide trial to evaluate efficacy of repurposed drugs for mild-to-moderate COVID-19

The University of Cincinnati is joining a nationwide study to evaluate repurposed medications in the search for effective, safe treatments for mild-to-moderate COVID-19. Repurposed medications are those already approved by the U.S. Food and Drug Administration for other indications.

16 Feb 2022

Study suggests tea polyphenols may modulate COVID-19 via intestinal microbiota

A new study discusses the state of current knowledge about the potential use of tea polyphenols in the prevention and treatment of COVID-19.

16 Feb 2022

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

SARS-CoV-2 Mpro inhibitor, nirmatrelvir, found to reduce COVID-19 progression and death

VA researchers shine light on the dangerous mental health consequences of COVID-19

‘I just want to stay in one spot’: From homeless to housed in rugged Del Norte

Study finds antigenic profile of Omicron RBD is distinct from the prior SARS-CoV-2 variants of concern

Covid-19 linked with an increased risk of mental health disorders, study finds

Ensitrelvir, a novel SARS-CoV-2 antiviral

New finding may aid in development of vaccines against future animal-to-human viral diseases

COVID-19 survivors more likely to suffer from mental health problems

2022 adult immunization schedule released by ACIP

ChAdOx1 vaccine found to protect Syrian hamsters against SARS-CoV-2 variants

Vaccination likely to be more protective against SARS-CoV-2 viral variants than natural infection

Frequency and function of SARS-CoV-2-specific T cells in individuals with pulmonary PASC

Study determines 115 long COVID symptoms and their associated risk factors

First cases of co-infection with Delta and Omicron identified during local co-circulation of both SARS-CoV-2 lineages

A novel consensus-based computational pipeline that reliably predicts hACE2-RBD binding affinity

Smartphone-based COVID-19 detection system

Study shows how some cancer cells immobilize T cells

Risk factors for COVID-19 in older adult patients with cancer

UC joins nationwide trial to evaluate efficacy of repurposed drugs for mild-to-moderate COVID-19

Study suggests tea polyphenols may modulate COVID-19 via intestinal microbiota

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Newsletters you may be interested in